Point-of-Care System for Determination of Bilirubin Capacity in Neonates

Completed

Conditions studied: Jaundice, Neonatal, Hyperbilirubinemia, Bilirubin-Induced Neurological Dysfunction (BIND)

In brief

The aims of this observational bench project are to validate the performance of the miniaturized and modernized hematofluorometer that measures bilirubin capacity into a product and is suitable for operation in various point of care environments w in the management of preterm neonates.

Key facts

Study ID

NCT02612207

Run by

Stanford University

People needed

161

Starts

2015-08-01

Expected to finish

2018-08-31

Last updated by the study team

2021-09-28

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• None.

Where it is running

• Lucile-Packard Children's Hospital at Stanford — Stanford, California, United States
• AVIV Biomedical, Inc. — Lakewood, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.